Biotest AG BIOTEST PREF SHS
Biotest AG BIOTEST PREF SHS/ DE0005227235 /
0N70
30/08/2024 15:36:33
|
Chg.
-1.90
|
Volume |
Bid- |
Ask- |
Market Capitalization |
Dividend Y. |
P/E Ratio |
25.00EUR
|
-7.06%
|
582,542 Turnover: 14.56 mill. |
-Bid Size: - |
-Ask Size: - |
1.62 bill.EUR |
0.10% |
- |
Fundamentals
|
FY 2021 |
Growth (1Y) |
Per Share |
|
Earnings per Share: |
-1.59 EUR |
103.85% |
EPS Diluted: |
-1.59 EUR |
103.85% |
Revenues per Share: |
13.03 EUR |
6.48% |
Book Value per Share: |
9.61 EUR |
-13.86% |
Cash Flow per Share: |
0.86 EUR |
- |
Dividend per Share: |
0.04 EUR |
0.00% |
Total |
in mill. |
|
Revenues: |
515.60 EUR |
6.48% |
Net Income: |
-63.40 EUR |
101.91% |
Operating Cash Flow: |
33.90 EUR |
- |
Cash and Cash Equivalents: |
104.40 EUR |
- |
Valuation Ratios
|
Current |
Latest FY* |
P/E Ratio: |
- |
- |
P/S Ratio: |
3.15 |
2.96 |
P/BV ratio: |
4.27 |
4.02 |
P/CF Ratio: |
47.86 |
45.06 |
PEG: |
-0.25 |
- |
Earnings Yield: |
-3.88% |
-4.12% |
Dividend Yield: |
0.10% |
0.10% |
Market Capitalization |
|
Market Capitalization: |
1.62 bill. EUR |
1.53 bill. EUR |
Free Float Market Cap.: |
811.23 mill. EUR |
763.74 mill. EUR |
Market Cap. / Employee: |
412,417.8953 EUR |
388,276.3599 EUR |
Shares Outstanding: |
19.79 mill. |
|
Profitability
Gross Profit Margin: |
15.65% |
EBIT Margin: |
-9.14% |
Net Profit Margin: |
-12.30% |
Return on Equity: |
-16.67% |
Return on Assets: |
-5.74% |
Financial Strength
Liquidity I / Cash Ratio: |
98.12% |
Liquidity II / Quick Ratio: |
198.97% |
Liquidity III / Current Ratio: |
490.79% |
Debt / Equity Ratio: |
190.27% |
Dynam. Debt / Equity Ratio: |
2,135.10% |
Efficiency
Employees: |
1,967 |
Personal Expenses / Employee: |
83,019.83 EUR |
Revenues / Employee: |
262,125.06 EUR |
Net Income / Employee: |
-32,231.83 EUR |
Total Assets / Employee: |
561,362.48 EUR |
* Fiscal Year End: |
31/12/2021 |
Accounting Standard: |
IFRS |